Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ziqin Lin
Institutions:
Sun Yat-sen University,
Sixth Affiliated Hospital of Sun Yat-sen University,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University,
Sixth Affiliated Hospital of Sun Yat-sen University,
State Key Laboratory of Oncology in South China
OpenAlex ID:
A5122836498
KRAS G12V mutation is associated with worse disease-free survival in patients with stage II colorectal cancer: a single-center retrospective study
2026
·
Xinrun Huang
, You Wu
, et al.
·
BMC Gastroenterology
Cetuximab plus capecitabine every three weeks as first-line maintenance therapy for RAS/BRAF wild-type metastatic colorectal cancer: a phase Ib dose-escalation study
2026
·
Xiaoyu Xie
, Ziqin Lin
, et al.
·
npj Precision Oncology
PDF
Abstract CT151: CDK4/6 inhibitor dalpiciclib combined with mFOLFOX6 in pretreated metastatic colorectal cancer: Results from a Simon two-stage phase II study
2026
·
Xiaoyu Xie
, Zhaoliang Yu
, et al.
·
Cancer Research
Efficacy and safety of triweekly cetuximab in combination with capecitabine as first-line maintenance treatment for KRAS/BRAF wild-type metastatic colorectal cancer: A phase Ib dose-escalation study.
2026
·
Xiaoyu Xie
, Ziqin Lin
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
4
Citation count:
H-index:
I10-index:
Year
Topic
Type